Total adverse events · acute gout
Non‐selective NSAIDs probably leads to higher total adverse events compared with selective cyclo‐oxygenase‐2 inhibitors (moderate certainty).
1 finding from 1 review
RR 1.94 [1.36, 2.78]
Studies not reported
Moderate
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · acute gout
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Swelling (mean) · acute gout
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Poor vision due to MO at 3 months after surgery · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower poor vision due to MO at 3 months after surgery compared with steroids (low certainty).
1 finding from 1 review
Poor vision due to MO at 12 months after surgery · patients undergoing cataract surgery
It is very uncertain whether NSAIDS plus steroids changes poor vision due to MO at 12 months after surgery compared with steroids (very low certainty).
1 finding from 1 review
Quality of life at 3 months after surgery · patients undergoing cataract surgery
1 finding from 1 review
Central retinal thickness at 3 months after surgery; · patients undergoing cataract surgery
1 finding from 1 review
Adverse effects · patients undergoing cataract surgery
1 finding from 1 review
MO at 3 months after cataract surgery, clinically symptomatic, · patients undergoing cataract surgery
NSAIDS plus steroids may leads to lower MO at 3 months after cataract surgery, clinically symptomatic, compared with steroids (low certainty).
1 finding from 1 review
Mean postoperative best‐corrected visual acuity · patients undergoing cataract surgery
1 finding from 1 review
Intraocular inflammation measured by anterior chamber cell and flare 1 week · people who received phacoemulsification
1 finding from 1 review
Intraocular inflammation measured by proportion of participants with corneal edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs showed no clear difference in intraocular inflammation measured by proportion of participants with… compared with corticosteroids (low certainty).
1 finding from 1 review
Proportion of participants with best‐corrected visual acuity of 20/40 1 week · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with cystoid macular edema 1 week · people who received phacoemulsification
Summary of findings for NSAIDs may leads to lower proportion of participants with cystoid macular edema 1 week compared with corticosteroids (low certainty).
1 finding from 1 review
Time to cessation of treatment · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic outcomes · people who received phacoemulsification
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acute postoperative pain 0 to 6 hours (Score 0 to 10, VAS or NRS Scale) · adults undergoing brain surgery
1 finding from 1 review
Length of hospital stay · adults undergoing brain surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event nausea and vomiting (0 to 24 hours) · adults undergoing brain surgery
Nonsteroidal anti‐inflammatory drugs (NSAIDs) showed no clear difference in adverse event nausea and vomiting (0 to 24 hours) compared with control or placebo medications (low certainty).
1 finding from 1 review